v3.25.1
Segment Information - Schedule of Revenue and Expense Categories of the Company’s Single Operating Segment (Unaudited) (Details) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating expenses:    
Clinical trial related service fee $ 1,375,000
Consulting fee 25,000 25,000
Stock-based compensation 159,095
Salary expense 129,711 120,486
Professional fee 285,090 199,156
Insurance expense 81,057 87,493
Other general and administrative fee 49,345 37,395
Loss before income tax 2,104,298 469,530
Income tax expense 13
Net loss $ 2,104,311 $ 469,530